Novonesis consensus takes shape, analysts map the stock’s chemistry niche
23.06.2026 - 17:15:13 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 17:09.
Novonesis (DK0060336014) is gaining visibility among research houses as the enzyme and industrial biotech group trades on Nasdaq Copenhagen. Consensus snapshots now give retail investors a clearer view of expectations for the transformed Novozymes business.
How analysts see Novonesis
Market data providers list Novonesis B as a Danish chemical and materials stock, with the shares quoted around 52 euros in Frankfurt-based trading indications for the NZM2 symbol, offering a proxy for the Copenhagen pricing in euro terms. Finanzen100’s Novonesis overview aggregates recent portfolio disclosures and sector news.
The same data page describes Novonesis, still often referenced under the Novozymes name, as active in chemistry, plastics and rubber materials, highlighting the company’s positioning in specialty industrial ingredients. The sector classification underlines how analysts compare the group with broader European chemicals peers rather than pure pharmaceuticals.
Consensus and sector context
Consensus commentary for European industrial biotech stocks increasingly mentions Novonesis alongside larger Nordic names such as Novo Nordisk when discussing the regional life science and chemistry cluster, even though Novonesis operates with a stronger focus on enzyme applications than on direct therapeutics. Financial Times markets data on Novo Nordisk illustrates the Copenhagen exchange’s role as a hub for global health and biotech investors.
Portfolio updates from European investment trusts that list Novonesis among their holdings show the stock used as a lever on industrial efficiency themes, placing it next to agriculture and bio-based materials names in fund strategies. Recent portfolio-disclosure headlines indicate that professional investors treat Novonesis as part of a long-term productivity and sustainability basket rather than a short-term cyclical trade.
Background and price data on Novonesis
Further articles and data points on the Novonesis shares, including additional consensus indications and trading details, are collected on the dedicated topic page and the company’s investor relations site.
The product behind the stock
Novonesis generates revenue primarily from enzyme solutions and microbial technologies used in industries ranging from detergents to food and bioenergy. The company’s portfolio includes laundry and dishwashing enzymes that help manufacturers improve cleaning performance at lower temperatures, aligning with energy-efficiency and sustainability targets.
Where the stock trades today
The Novonesis shares (DK0060336014) trade on Nasdaq Copenhagen, with parallel indications for the NZM2 symbol showing around 52 euros in Frankfurt quotations as of 2026-06-23, 17:09.
Key data on the Novonesis shares
- Company: Novonesis A/S
- ISIN: DK0060336014
- WKN: A1JP9Y
- Ticker: NZM2 (Frankfurt indication), primary listing on Nasdaq Copenhagen
- Trading venue: Nasdaq Copenhagen
- Price (as of 2026-06-23, 17:09): 52.22 euros (Frankfurt indication)
- Market cap: not specified in public snapshots for the Frankfurt indication on this date
- Sector / industry: Chemicals, plastics and rubber materials; industrial biotechnology and enzymes
- Index membership: not documented as part of a major headline index in the checked sources
- Next earnings date: not officially scheduled in the publicly accessible investor calendar at the time of writing
Disclaimer: This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any form of financial promotion. All data are based on publicly available sources checked at the time of writing and may change without notice.
